Detalhe da pesquisa
1.
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.
BMC Med
; 20(1): 493, 2022 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581917
2.
Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
Ann Thorac Surg
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309611
3.
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study.
Signal Transduct Target Ther
; 9(1): 145, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38871690
4.
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.
Genome Med
; 15(1): 14, 2023 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869384
5.
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study.
Nat Commun
; 14(1): 4655, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537219
6.
Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer.
Ann Thorac Surg
; 114(3): 949-958, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176262
7.
Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case report.
Ann Transl Med
; 9(8): 724, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987422
8.
Outcomes of sleeve lobectomy versus pneumonectomy: A propensity score-matched study.
J Thorac Cardiovasc Surg
; 162(6): 1619-1628.e4, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919775
9.
Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer.
Genome Biol
; 21(1): 152, 2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580738